141 related articles for article (PubMed ID: 29550331)
1. Hydroxychavicol, a key ingredient of Piper betle induces bacterial cell death by DNA damage and inhibition of cell division.
Singh D; Narayanamoorthy S; Gamre S; Majumdar AG; Goswami M; Gami U; Cherian S; Subramanian M
Free Radic Biol Med; 2018 May; 120():62-71. PubMed ID: 29550331
[TBL] [Abstract][Full Text] [Related]
2. Phytochemical Analysis, Identification and Quantification of Antibacterial Active Compounds in Betel Leaves, Piper betle Methanolic Extract.
Syahidah A; Saad CR; Hassan MD; Rukayadi Y; Norazian MH; Kamarudin MS
Pak J Biol Sci; 2017; 20(2):70-81. PubMed ID: 29022997
[TBL] [Abstract][Full Text] [Related]
3. Membrane damage precedes DNA damage in hydroxychavicol treated E. coli cells and facilitates cooperativity with hydrophobic antibiotics.
Singh D; Majumdar AG; Gamre S; Subramanian M
Biochimie; 2021 Jan; 180():158-168. PubMed ID: 33181225
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychavicol, a polyphenol from
Rajedadram A; Pin KY; Ling SK; Yan SW; Looi ML
J Zhejiang Univ Sci B; 2021 Feb; 22(2):112-122. PubMed ID: 33615752
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychavicol from Piper betle induces apoptosis, cell cycle arrest, and inhibits epithelial-mesenchymal transition in pancreatic cancer cells.
Guha Majumdar A; Subramanian M
Biochem Pharmacol; 2019 Aug; 166():274-291. PubMed ID: 31154000
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychavicol: a potent xanthine oxidase inhibitor obtained from the leaves of betel, Piper betle.
Murata K; Nakao K; Hirata N; Namba K; Nomi T; Kitamura Y; Moriyama K; Shintani T; Iinuma M; Matsuda H
J Nat Med; 2009 Jul; 63(3):355-9. PubMed ID: 19387769
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis.
Gundala SR; Yang C; Mukkavilli R; Paranjpe R; Brahmbhatt M; Pannu V; Cheng A; Reid MD; Aneja R
Toxicol Appl Pharmacol; 2014 Oct; 280(1):86-96. PubMed ID: 25064160
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory potential of Hydroxychavicol on Ehrlich ascites carcinoma model and
Hemamalini V; Velayutham DPM; Lakshmanan L; Muthusamy K; Sivaramakrishnan S; Premkumar K
Nat Prod Res; 2020 Jun; 34(11):1591-1596. PubMed ID: 30470141
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal activity of hydroxychavicol isolated from Piper betle L.
Ali I; Khan FG; Suri KA; Gupta BD; Satti NK; Dutt P; Afrin F; Qazi GN; Khan IA
Ann Clin Microbiol Antimicrob; 2010 Feb; 9():7. PubMed ID: 20128889
[TBL] [Abstract][Full Text] [Related]
10. A new hydroxychavicol dimer from the roots of Piper betle.
Lin CF; Hwang TL; Chien CC; Tu HY; Lay HL
Molecules; 2013 Feb; 18(3):2563-70. PubMed ID: 23442932
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Potential of Hydroxychavicol Derived from
Vinusri S; Gnanam R; Caroline R; Santhanakrishnan VP; Kandavelmani A
Nutr Cancer; 2022; 74(10):3701-3713. PubMed ID: 35703834
[No Abstract] [Full Text] [Related]
12. Hydroxychavicol modulates benzo[a]pyrene-induced genotoxicity through induction of dihydrodiol dehydrogenase.
Tang DW; Chang KW; Chi CW; Liu TY
Toxicol Lett; 2004 Sep; 152(3):235-43. PubMed ID: 15331132
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial, antibiofilm, and anti-adhesion activities of Piper betle leaf extract against Avian pathogenic Escherichia coli.
Kulnanan P; Chuprom J; Thomrongsuwannakij T; Romyasamit C; Sangkanu S; Manin N; Nissapatorn V; de Lourdes Pereira M; Wilairatana P; Kitpipit W; Mitsuwan W
Arch Microbiol; 2021 Dec; 204(1):49. PubMed ID: 34935071
[TBL] [Abstract][Full Text] [Related]
14. Betelvine (Piper betle L.): A comprehensive insight into its ethnopharmacology, phytochemistry, and pharmacological, biomedical and therapeutic attributes.
Biswas P; Anand U; Saha SC; Kant N; Mishra T; Masih H; Bar A; Pandey DK; Jha NK; Majumder M; Das N; Gadekar VS; Shekhawat MS; Kumar M; Radha ; Proćków J; Lastra JMP; Dey A
J Cell Mol Med; 2022 Jun; 26(11):3083-3119. PubMed ID: 35502487
[TBL] [Abstract][Full Text] [Related]
15. The new ether derivative of phenylpropanoid and bioactivity was investigated from the leaves of
Atiya A; Sinha BN; Lal UR
Nat Prod Res; 2020 Mar; 34(5):638-645. PubMed ID: 30169967
[TBL] [Abstract][Full Text] [Related]
16.
Nayaka NMDMW; Sasadara MMV; Sanjaya DA; Yuda PESK; Dewi NLKAA; Cahyaningsih E; Hartati R
Molecules; 2021 Apr; 26(8):. PubMed ID: 33923576
[No Abstract] [Full Text] [Related]
17. An experimental evaluation of the anti-atherogenic potential of the plant, Piper betle, and its active constitutent, eugenol, in rats fed an atherogenic diet.
Venkadeswaran K; Thomas PA; Geraldine P
Biomed Pharmacother; 2016 May; 80():276-288. PubMed ID: 27133067
[TBL] [Abstract][Full Text] [Related]
18.
Sekar V; Ramasamy G; Ravikumar C
Drug Dev Ind Pharm; 2022 May; 48(5):169-188. PubMed ID: 35311433
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug Resistance.
Valle DL; Cabrera EC; Puzon JJ; Rivera WL
PLoS One; 2016; 11(1):e0146349. PubMed ID: 26741962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
